DOBUTAMINE INJECTION USP
HIKMA CANADA LIMITED
Quick answers
Is there a shortage of DOBUTAMINE INJECTION USP in Canada?
No. There is no current shortage of DOBUTAMINE INJECTION USP 12.5MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
DOBUTREX
PHARMACEUTICAL PARTNERS OF CANADA INC
DOBUTAMINE 12.5MG/ML
IVAX PHARMACEUTICALS INCORPORATED
DOBUTAMINE INJECTION SDZ
SANDOZ CANADA INCORPORATED
Other Products
DOBUTAMINE HYDROCHLORIDE INJECTION-12.5MG/ML
NOVOPHARM LIMITED
DOBUTAMINE INJECTION USP
PFIZER CANADA ULC
DIN
02462729
Strength
12.5MG
Dosage Form
Solution
Route
Intravenous
Active Ingredient
DOBUTAMINE (DOBUTAMINE HYDROCHLORIDE)
See all DOBUTAMINE (DOBUTAMINE HYDROCHLORIDE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from HIKMA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
9MG · DIN 02304341
200MG · DIN 02459906
0.6MG · DIN 02432196
0.4MG · DIN 02432188
100MG · DIN 02507668
2MG · DIN 02457075
0.05MG · DIN 02457059
0.2% · DIN 02515377
1G · DIN 02437112
500MG · DIN 02437104
10G · DIN 02437120
2G · DIN 02499096